Capricor Therapeutics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KNov. 10, 2026, 4:05 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedCapricor Therapeutics Q3 2026 EPS of -$0.73 Misses -$0.41 Consensus; Zero Revenue Against $10.4 Million Expected
8-KAug. 24, 2026, 9:25 a.m. ETView on SEC.gov
Other events · Financial statements and exhibits
8-KAug. 13, 2026, 4:07 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
8-KJuly 30, 2026, 4:05 p.m. ETView on SEC.gov
Other events · Financial statements and exhibits
8-KJuly 29, 2026, 10:05 a.m. ETView on SEC.gov
Other events · Financial statements and exhibits